215 related articles for article (PubMed ID: 18508421)
21. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.
Kapoor D; Clarke S; Channer KS; Jones TH
Int J Androl; 2007 Dec; 30(6):500-7. PubMed ID: 18028199
[TBL] [Abstract][Full Text] [Related]
22. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.
El-Sakka AI; Sayed HM; Tayeb KA
Urology; 2009 Sep; 74(3):552-9. PubMed ID: 19592073
[TBL] [Abstract][Full Text] [Related]
23. Association of metabolic syndrome, atherosclerosis risk factors, sex hormones in ED in aboriginal Taiwanese.
Chao JK; Kuo WH; Chiang HS; Hwang TI; Chao IC; Chiang SK
Int J Impot Res; 2012; 24(4):141-6. PubMed ID: 22495625
[TBL] [Abstract][Full Text] [Related]
24. The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction.
Aslan Y; Guzel O; Balci M; Tuncel A; Yildiz M; Atan A
Aging Male; 2014 Jun; 17(2):76-80. PubMed ID: 24576299
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO.
Ma WY; Li HY; Hung CS; Lin MS; Chiu FC; Lin CH; Shih SR; Chuang LM; Wei JN
Diabetes Res Clin Pract; 2009 Sep; 85(3):335-41. PubMed ID: 19608293
[TBL] [Abstract][Full Text] [Related]
26. Testosterone levels in men with erectile dysfunction.
Martínez-Jabaloyas JM; Queipo-Zaragozá A; Pastor-Hernández F; Gil-Salom M; Chuan-Nuez P
BJU Int; 2006 Jun; 97(6):1278-83. PubMed ID: 16686726
[TBL] [Abstract][Full Text] [Related]
27. Is the metabolic syndrome an independent risk factor for erectile dysfunction?
Heidler S; Temml C; Broessner C; Mock K; Rauchenwald M; Madersbacher S; Ponholzer A
J Urol; 2007 Feb; 177(2):651-4. PubMed ID: 17222651
[TBL] [Abstract][Full Text] [Related]
28. Can the International Index of Erectile Function distinguish between organic and psychogenic erectile function?
Deveci S; O'Brien K; Ahmed A; Parker M; Guhring P; Mulhall JP
BJU Int; 2008 Aug; 102(3):354-6. PubMed ID: 18336609
[TBL] [Abstract][Full Text] [Related]
29. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction.
Rhoden EL; Telöken C; Sogari PR; Vargas Souto CA
Int J Impot Res; 2002 Aug; 14(4):245-50. PubMed ID: 12152112
[TBL] [Abstract][Full Text] [Related]
30. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations.
Assmann G; Guerra R; Fox G; Cullen P; Schulte H; Willett D; Grundy SM
Am J Cardiol; 2007 Feb; 99(4):541-8. PubMed ID: 17293200
[TBL] [Abstract][Full Text] [Related]
31. Erectile dysfunction in Singapore: prevalence and its associated factors--a population-based study.
Tan JK; Hong CY; Png DJ; Liew LC; Wong ML
Singapore Med J; 2003 Jan; 44(1):20-6. PubMed ID: 12762559
[TBL] [Abstract][Full Text] [Related]
32. The associations among eNOS G894T gene polymorphism, erectile dysfunction and related risk factors.
Lee YC; Huang CH; Wang CJ; Liu CC; Wu WJ; Chang LL; Lin HH
BJU Int; 2007 Nov; 100(5):1116-20. PubMed ID: 17868426
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
34. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
35. Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men.
Levisianou D; Melidonis A; Adamopoulou E; Skopelitis E; Koutsovasilis A; Protopsaltis I; Zairis M; Kougialis S; Skoularigis I; Koukoulis G; Foussas S; Triposkiadis F
Int Angiol; 2009 Dec; 28(6):490-5. PubMed ID: 20087288
[TBL] [Abstract][Full Text] [Related]
36. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction.
El-Sakka AI; Sayed HM; Tayeb KA
Int J Androl; 2008 Dec; 31(6):602-8. PubMed ID: 17877718
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire.
Ponholzer A; Temml C; Mock K; Marszalek M; Obermayr R; Madersbacher S
Eur Urol; 2005 Jan; 47(1):80-5; discussion 85-6. PubMed ID: 15582253
[TBL] [Abstract][Full Text] [Related]
38. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction.
Makhlouf AA; Mohamed MA; Seftel AD; Niederberger C
Int J Impot Res; 2008; 20(2):157-61. PubMed ID: 17703222
[TBL] [Abstract][Full Text] [Related]
39. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
[TBL] [Abstract][Full Text] [Related]
40. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
